CRL · Company research
Charles River Laboratories International, Inc. (CRL): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 300.3 | $14,276,217,840 | 14084192840.00 | 194.7032258064516129 | — | — | 14.2182358741053982 | 4.9423868428441209 | 96.0585240209931358 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.